News
Guska at LSX World Congress
Nicolás Tambucho, CEO of Guska, took part in the LSX World Congress in Lisbon as part of Spring Innovation Week. “It was a highly enriching experience, where we connected with the biotech ecosystem, learned from industry leaders, and held meetings that bring us closer to advancing our developments,” he noted. Tambucho also presented Guska’s...
B4-RNA and Resolve Therapeutics Will Collaborate to Analyze Cell-Free RNA in Autoimmunity Using Proprietary Sequencing Technology
B4-RNA, a startup backed by LAB+ that works with RNA, announced a collaboration with Resolve Therapeutics. The collaboration will identify inflammatory RNA molecules circulating in the bloodstream of patients with autoimmune diseases that could become potential drug targets. Cell-free RNA (cfRNA) molecules circulating in human blood are emerging...
Guska Develops AI Platform MVP for Oncolytic Viruses
Guska, in partnership with Marvik, has developed an artificial intelligence platform that will enhance the startup’s work designing viruses capable of fighting cancer without harming healthy cells. This milestone makes it possible to plan and design treatment options before testing them in the laboratory. This first operational version—known as a...
Read the second edition of our newsletter here.
(It’s in Spanish, but there’s a translation option at the top right of the menu)
Read the first edition here.
LAB+ in the Media:
Local
Radio Sarandí – Interview with Matías Machado about Scaffold Biotech’s cattle tick vaccine
El País – The five key features of the Uruguayan vaccine that could change the fight against ticks
Radio Sarandí – Carlos Batthyány talks about Lab+, the vaccine developed by Scaffold Biotech, and the drug from Eolo Pharma
InfoNegocios – A Uruguayan startup dedicated to early cancer diagnosis adds a former dLocal member as CEO
Forbes Uruguay – Interview with Carlos Batthyány about LAB+ and the Institut Pasteur de Montevideo
Búsqueda – International call for startups, interview with Carlos Batthyány and Paul Elberse
En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’
Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio
En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer
La Diaria – What do the first four start-ups of the LAB+ seek to develop?
Telemundo (Channel 12) – Scaffold Biotech: more efficient vaccines for animals
En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska
Subrayado (Channel 10) – LAB+ closed its first financing cycle
Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+
La Diaria – Conversations with the first four biotech start-ups funded by LAB+
El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups
Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups
Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA
Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups
El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?
Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative
Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies
International
El Ecosistema Startup – Scaffold Biotech’s tick vaccine
Infobae – Uruguayan scientists develop a vaccine against cattle tick
Yale Podcasts – Interview with Gonzalo Moratorio, Guska’s founder
Tekios – LAB+ international call for scientific projects and start-ups
SwissInfo – LAB+ international call for scientific projects and start-ups
Latin American Post – LAB+ pioneers a new era of scientific start-ups in Uruguay and beyond.
Infobae – Closing of first round of financing for LAB+.
EFE – The Institut Pasteur de Montevideo presents LAB+, with four start-ups.
Investing – The Institut Pasteur de Montevideo launches the LAB+ iniciative.
ABC (Paraguay) – With four start-ups, the Institut Pasteur de Montevideo launches the LAB+.
Bloomberg – New Venture Capital Fund Eyes Latin American Science Start-ups.
Bloomberg online – New venture capital fund sets its sights on Latin American scientific start-ups.
Perfil – A new venture capital fund targets Latin American science.
iProUP – Support for startups: Ficus Capital, biotech fund, looks for unicorns in Latin America.
Yahoo Finances – Biotech fund seeks unicorns in LatAm.